Best-in-Class Therapies for Immunological and Inflammatory Disorders
Apogee Therapeutics is a clinical-stage biotechnology company developing novel antibody therapeutics for inflammatory and immune diseases, including atopic dermatitis, asthma, and eosinophilic esophagitis. Founded 2022 and headquartered in South San Francisco, the company's lead program zumilokibart (APG777) targets IL-13 and is in Phase 2 trials.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJul 2023
Dec 2022
Feb 2022
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
